Cargando…

Patient-reported patterns of follow-up care in the ‘Aftercare in Blood Cancer Survivors’ (ABC) study

BACKGROUND: Follow-up care provides long-term support for cancer survivors. Little is known about follow-up care in hematologic malignancies. METHODS: Our questionnaire-based study included blood cancer survivors diagnosed at the University Hospital of Essen before 2010, with a ≥ 3-year interval sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Baum, Julia, Lax, Hildegard, Lehmann, Nils, Merkel-Jens, Anja, Beelen, Dietrich W., Jöckel, Karl-Heinz, Dührsen, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423115/
https://www.ncbi.nlm.nih.gov/pubmed/37291404
http://dx.doi.org/10.1007/s00432-023-04889-7
_version_ 1785089375188549632
author Baum, Julia
Lax, Hildegard
Lehmann, Nils
Merkel-Jens, Anja
Beelen, Dietrich W.
Jöckel, Karl-Heinz
Dührsen, Ulrich
author_facet Baum, Julia
Lax, Hildegard
Lehmann, Nils
Merkel-Jens, Anja
Beelen, Dietrich W.
Jöckel, Karl-Heinz
Dührsen, Ulrich
author_sort Baum, Julia
collection PubMed
description BACKGROUND: Follow-up care provides long-term support for cancer survivors. Little is known about follow-up care in hematologic malignancies. METHODS: Our questionnaire-based study included blood cancer survivors diagnosed at the University Hospital of Essen before 2010, with a ≥ 3-year interval since the last intense treatment. The primary goal of the retrospective study was the identification and characterization of follow-up institutions. RESULTS: Of 2386 survivors meeting the inclusion criteria, 1551 (65.0%) consented to participate, with a follow-up duration > 10 years in 731. The university hospital provided care for 1045 participants (67.4%), non-university oncologists for 231 (14.9%), and non-oncological internists or general practitioners for 203 (13.1%). Seventy-two participants (4.6%) abstained from follow-up care. The disease spectrum differed among follow-up institutions (p < 0.0001). While allogeneic transplant recipients clustered at the university hospital, survivors with monoclonal gammopathy, multiple myeloma, myeloproliferative disorders, or indolent lymphomas were often seen by non-university oncologists, and survivors with a history of aggressive lymphoma or acute leukemia by non-oncological internists or general practitioners. Follow-up intervals mirrored published recommendations. Follow-up visits were dominated by conversations, physical examination, and blood tests. Imaging was more often performed outside than inside the university hospital. Satisfaction with follow-up care was high, and quality of life was similar in all follow-up institutions. A need for improvement was reported in psychosocial support and information about late effects. CONCLUSIONS: The naturally evolved patterns identified in the study resemble published care models: Follow-up clinics for complex needs, specialist-led care for unstable disease states, and general practitioner-led care for stable conditions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04889-7.
format Online
Article
Text
id pubmed-10423115
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-104231152023-08-14 Patient-reported patterns of follow-up care in the ‘Aftercare in Blood Cancer Survivors’ (ABC) study Baum, Julia Lax, Hildegard Lehmann, Nils Merkel-Jens, Anja Beelen, Dietrich W. Jöckel, Karl-Heinz Dührsen, Ulrich J Cancer Res Clin Oncol Research BACKGROUND: Follow-up care provides long-term support for cancer survivors. Little is known about follow-up care in hematologic malignancies. METHODS: Our questionnaire-based study included blood cancer survivors diagnosed at the University Hospital of Essen before 2010, with a ≥ 3-year interval since the last intense treatment. The primary goal of the retrospective study was the identification and characterization of follow-up institutions. RESULTS: Of 2386 survivors meeting the inclusion criteria, 1551 (65.0%) consented to participate, with a follow-up duration > 10 years in 731. The university hospital provided care for 1045 participants (67.4%), non-university oncologists for 231 (14.9%), and non-oncological internists or general practitioners for 203 (13.1%). Seventy-two participants (4.6%) abstained from follow-up care. The disease spectrum differed among follow-up institutions (p < 0.0001). While allogeneic transplant recipients clustered at the university hospital, survivors with monoclonal gammopathy, multiple myeloma, myeloproliferative disorders, or indolent lymphomas were often seen by non-university oncologists, and survivors with a history of aggressive lymphoma or acute leukemia by non-oncological internists or general practitioners. Follow-up intervals mirrored published recommendations. Follow-up visits were dominated by conversations, physical examination, and blood tests. Imaging was more often performed outside than inside the university hospital. Satisfaction with follow-up care was high, and quality of life was similar in all follow-up institutions. A need for improvement was reported in psychosocial support and information about late effects. CONCLUSIONS: The naturally evolved patterns identified in the study resemble published care models: Follow-up clinics for complex needs, specialist-led care for unstable disease states, and general practitioner-led care for stable conditions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04889-7. Springer Berlin Heidelberg 2023-06-08 2023 /pmc/articles/PMC10423115/ /pubmed/37291404 http://dx.doi.org/10.1007/s00432-023-04889-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Baum, Julia
Lax, Hildegard
Lehmann, Nils
Merkel-Jens, Anja
Beelen, Dietrich W.
Jöckel, Karl-Heinz
Dührsen, Ulrich
Patient-reported patterns of follow-up care in the ‘Aftercare in Blood Cancer Survivors’ (ABC) study
title Patient-reported patterns of follow-up care in the ‘Aftercare in Blood Cancer Survivors’ (ABC) study
title_full Patient-reported patterns of follow-up care in the ‘Aftercare in Blood Cancer Survivors’ (ABC) study
title_fullStr Patient-reported patterns of follow-up care in the ‘Aftercare in Blood Cancer Survivors’ (ABC) study
title_full_unstemmed Patient-reported patterns of follow-up care in the ‘Aftercare in Blood Cancer Survivors’ (ABC) study
title_short Patient-reported patterns of follow-up care in the ‘Aftercare in Blood Cancer Survivors’ (ABC) study
title_sort patient-reported patterns of follow-up care in the ‘aftercare in blood cancer survivors’ (abc) study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423115/
https://www.ncbi.nlm.nih.gov/pubmed/37291404
http://dx.doi.org/10.1007/s00432-023-04889-7
work_keys_str_mv AT baumjulia patientreportedpatternsoffollowupcareintheaftercareinbloodcancersurvivorsabcstudy
AT laxhildegard patientreportedpatternsoffollowupcareintheaftercareinbloodcancersurvivorsabcstudy
AT lehmannnils patientreportedpatternsoffollowupcareintheaftercareinbloodcancersurvivorsabcstudy
AT merkeljensanja patientreportedpatternsoffollowupcareintheaftercareinbloodcancersurvivorsabcstudy
AT beelendietrichw patientreportedpatternsoffollowupcareintheaftercareinbloodcancersurvivorsabcstudy
AT jockelkarlheinz patientreportedpatternsoffollowupcareintheaftercareinbloodcancersurvivorsabcstudy
AT duhrsenulrich patientreportedpatternsoffollowupcareintheaftercareinbloodcancersurvivorsabcstudy